FDA.reportPublic FDA data

NRAS gene mutation IVD, reagent

Definition
A substance or reactant intended to be used together with a parent IVD to perform a specific function in an assay that is used to monitor or predict the neuroblastoma RAS viral (v-ras) oncogene homolog (NRAS gene) mutation status of a tumour tissue specimen.
GUDID devices
3
Last updated
2020-03-25 20:50:27

Representative GUDID Devices#

Primary DI, Brand, Company table
Primary DIBrandCompanyModelPublished
L502BSB2666NRAS RMabBIO SB, INC.Concentrate, 0.1 ml2020-03-16
L502BSB2667NRAS RMabBIO SB, INC.Concentrate, 0.5 ml2020-03-16
L502BSB2668NRAS RMabBIO SB, INC.Concentrate, 1 ml2020-03-16